Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serelaxin PK/Safety in Pediatric Acute Heart Failure
NCT02151383Phase 2Terminated
- Sponsor
- Novartis
- Start
- Sep 2014
- Primary completion
- Apr 2017
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 4
01
Overview
A Phase 2 trial of serelaxin in Acute Heart Failure (AHF), sponsored by Novartis. Started Sep 2014; status: terminated.
02
Drugs
serelaxin
03
Conditions
Acute Heart Failure (AHF)
Beyond the preview
Go deeper on NCT02151383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02151383.